BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2463974)

  • 1. Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats.
    Inamura N; Hashimoto M; Nakahara K; Nakajima Y; Nishio M; Aoki H; Yamaguchi I; Kohsaka M
    Int J Immunopharmacol; 1988; 10(8):991-5. PubMed ID: 2463974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effect of FK506 on collagen-induced arthritis in rats.
    Inamura N; Hashimoto M; Nakahara K; Aoki H; Yamaguchi I; Kohsaka M
    Clin Immunol Immunopathol; 1988 Jan; 46(1):82-90. PubMed ID: 2446810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotropin inhibits experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Naiki M; Takeoka Y; Kurimoto Y; Matsuoka T; Suehiro S; Imai Y; Osawa T; Gershwin ME
    Int J Immunopharmacol; 1991; 13(2-3):235-43. PubMed ID: 1712761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
    Strejan GH; Percy DH; St Louis J
    Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
    Miller A; Lider O; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
    Strejan GH; St Louis J
    Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
    al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
    Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide.
    MacPhee IA; Day MJ; Mason DW
    Immunology; 1990 Aug; 70(4):527-34. PubMed ID: 1697565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Khoury SJ; Lider O; al-Sabbagh A; Weiner HL
    Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
    Bolton C; Allsopp G; Cuzner ML
    Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
    MacPhee IA; Mason DW
    J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
    Wang ZY; He B; Qiao J; Link H
    J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacological studies on experimental allergic encephalomyelitis in DA rats.
    Nagai H; Goto M; Kamada H; Boda K; Kitagaki K; Takaoka Y
    Gen Pharmacol; 1998 Feb; 30(2):161-6. PubMed ID: 9502169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S; Zielasek J; Köllner G; Donhauser T; Toyka K; Hartung HP
    J Neuroimmunol; 1996 Aug; 68(1-2):1-11. PubMed ID: 8784254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.